{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:57:30Z","timestamp":1790517450984,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/02258"],"award-info":[{"award-number":["PI13\/02258"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/02123"],"award-info":[{"award-number":["PI17\/02123"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00535"],"award-info":[{"award-number":["PI20\/00535"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0014\/0010"],"award-info":[{"award-number":["RD12\/0014\/0010"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0019\/0003"],"award-info":[{"award-number":["RD16\/0019\/0003"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0019\/0004"],"award-info":[{"award-number":["RD16\/0019\/0004"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0019\/0009"],"award-info":[{"award-number":["RD16\/0019\/0009"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regional Madrid Government","award":["B2017\/BMD- 3688"],"award-info":[{"award-number":["B2017\/BMD- 3688"]}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2019-106581RB-I00"],"award-info":[{"award-number":["PID2019-106581RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leducq Foundation for Cardiovascular Research","award":["TNE-19CVD01"],"award-info":[{"award-number":["TNE-19CVD01"]}]},{"name":"Fundacio\u0301n La Caixa","award":["HR17_00527"],"award-info":[{"award-number":["HR17_00527"]}]},{"DOI":"10.13039\/100008722","name":"Universitat de Girona","doi-asserted-by":"publisher","award":["IF-UdG 2015"],"award-info":[{"award-number":["IF-UdG 2015"]}],"id":[{"id":"10.13039\/100008722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12035-021-02644-y","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T23:47:29Z","timestamp":1641340049000},"page":"1320-1332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration"],"prefix":"10.1007","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8378-4477","authenticated-orcid":false,"given":"Carme","family":"Gubern-M\u00e9rida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-4723","authenticated-orcid":false,"given":"Pau","family":"Comajoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1439-5053","authenticated-orcid":false,"given":"Gemma","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Garc\u00eda-Yebenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6028-7379","authenticated-orcid":false,"given":"Ignacio","family":"Lizasoain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-8237","authenticated-orcid":false,"given":"Mar\u00eda Angeles","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0572-588X","authenticated-orcid":false,"given":"Irene","family":"Puig-Parnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4139-7273","authenticated-orcid":false,"given":"Juan Manuel","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-7744","authenticated-orcid":false,"given":"Joaqu\u00edn","family":"Serena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-4637","authenticated-orcid":false,"given":"Elisabet","family":"K\u00e1d\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3116-1352","authenticated-orcid":false,"given":"Mar","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"2644_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1177\/1747493020909545","volume":"15","author":"J Kim","year":"2020","unstructured":"Kim J, Thayabaranathan T, Donnan GA et al (2020) Global Stroke Statistics 2019. Int J Stroke 15:819\u2013838. https:\/\/doi.org\/10.1177\/1747493020909545","journal-title":"Int J Stroke"},{"key":"2644_CR2","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(18)31269-8","volume":"392","author":"JD Pandian","year":"2018","unstructured":"Pandian JD, Gall SL, Kate MP et al (2018) Prevention of stroke: a global perspective. Lancet 392:1269\u20131278. https:\/\/doi.org\/10.1016\/S0140-6736(18)31269-8","journal-title":"Lancet"},{"key":"2644_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20194845","volume":"20","author":"R Fusco","year":"2019","unstructured":"Fusco R, Scuto M, Cordaro M et al (2019) N-palmitoylethanolamide-oxazoline protects against middle cerebral artery occlusion injury in diabetic rats by regulating the SIRT1 pathway. Int J Mol Sci 20:1\u201322. https:\/\/doi.org\/10.3390\/ijms20194845","journal-title":"Int J Mol Sci"},{"key":"2644_CR4","doi-asserted-by":"crossref","unstructured":"Powers WJ, Rabinstein AA, Ackerson T et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association\/American Stroke A","DOI":"10.1161\/STR.0000000000000211"},{"key":"2644_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2396987318786023","volume":"4","author":"D Aguiar de Sousa","year":"2019","unstructured":"Aguiar de Sousa D, von Martial R, Abilleira S et al (2019) Access to and delivery of acute ischaemic stroke treatments: a survey of national scientific societies and stroke experts in 44 European countries. Eur Stroke J 4:13\u201328. https:\/\/doi.org\/10.1177\/2396987318786023","journal-title":"Eur Stroke J"},{"key":"2644_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-020-00985-1","author":"C Liu","year":"2020","unstructured":"Liu C, Xie J, Sun S et al (2020) Hemorrhagic transformation after tissue plasminogen activator treatment in acute ischemic stroke. Cell Mol Neurobiol. https:\/\/doi.org\/10.1007\/s10571-020-00985-1","journal-title":"Cell Mol Neurobiol"},{"key":"2644_CR7","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.neuropharm.2009.12.017","volume":"58","author":"RA Fanne","year":"2010","unstructured":"Fanne RA, Nassar T, Yarovoi S et al (2010) Blood-brain barrier permeability and tPA-mediated neurotoxicity. Neuropharmacology 58:972\u2013980. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.12.017","journal-title":"Neuropharmacology"},{"key":"2644_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/ana.22538","volume":"70","author":"SJ Won","year":"2011","unstructured":"Won SJ, Tang XN, Suh SW et al (2011) Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by increasing superoxide production. Ann Neurol 70:583\u2013590. https:\/\/doi.org\/10.1002\/ana.22538","journal-title":"Ann Neurol"},{"key":"2644_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/187152708784936608","volume":"7","author":"R Adibhatla","year":"2008","unstructured":"Adibhatla R, Hatcher J (2008) Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Disord - Drug Targets 7:243\u2013253. https:\/\/doi.org\/10.2174\/187152708784936608","journal-title":"CNS Neurol Disord - Drug Targets"},{"key":"2644_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1515\/revneuro-2013-0039","volume":"25","author":"YL Zhao","year":"2014","unstructured":"Zhao YL, Song JN, Zhang M (2014) Role of caveolin-1 in the biology of the blood-brain barrier. Rev Neurosci 25:247\u2013254. https:\/\/doi.org\/10.1515\/revneuro-2013-0039","journal-title":"Rev Neurosci"},{"key":"2644_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173795","author":"M Zhou","year":"2021","unstructured":"Zhou M, Shi SX, Liu N et al (2021) Caveolae-mediated endothelial transcytosis across the blood-brain barrier in acute ischemic stroke. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10173795","journal-title":"J Clin Med"},{"key":"2644_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1471-4159.2011.07542.x","volume":"120","author":"Y Gu","year":"2012","unstructured":"Gu Y, Zheng G, Xu M et al (2012) Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem 120:147\u2013156. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07542.x","journal-title":"J Neurochem"},{"key":"2644_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/01.RES.0000260180.42709.29","volume":"100","author":"J-FJF Jasmin","year":"2007","unstructured":"Jasmin J-FJF, Malhotra S, Singh Dhallu M et al (2007) Caveolin-1 deficiency increases cerebral ischemic injury. Circ Res 100:721\u2013729. https:\/\/doi.org\/10.1161\/01.RES.0000260180.42709.29","journal-title":"Circ Res"},{"key":"2644_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00401-007-0274-x","volume":"114","author":"S Nag","year":"2007","unstructured":"Nag S, Venugopalan R, Stewart DJ (2007) Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta Neuropathol 114:459\u2013469. https:\/\/doi.org\/10.1007\/s00401-007-0274-x","journal-title":"Acta Neuropathol"},{"key":"2644_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0149269","volume":"11","author":"H Song","year":"2016","unstructured":"Song H, Cheng Y, Bi G et al (2016) Release of matrix metalloproteinases-2 and 9 by S-nitrosylated caveolin-1 contributes to degradation of extracellular matrix in tPA-treated hypoxic endothelial cells. PLoS ONE 11:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0149269","journal-title":"PLoS ONE"},{"key":"2644_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2990.2008.01009.x","volume":"35","author":"S Nag","year":"2009","unstructured":"Nag S, Manias JLL, Stewart DJJ (2009) Expression of endothelial phosphorylated caveolin-1 is increased in brain injury. Neuropathol Appl Neurobiol 35:417\u2013426. https:\/\/doi.org\/10.1111\/j.1365-2990.2008.01009.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2644_CR17","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/STROKEAHA.110.600452","volume":"42","author":"I Garc\u00eda-Y\u00e9benes","year":"2011","unstructured":"Garc\u00eda-Y\u00e9benes I, Sobrado M, Zarruk JGG et al (2011) A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke. Stroke 42:196\u2013203. https:\/\/doi.org\/10.1161\/STROKEAHA.110.600452","journal-title":"Stroke"},{"key":"2644_CR18","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/978-1-4939-5620-3_6","volume":"38","author":"O Cyrille","year":"2007","unstructured":"Cyrille O, Audrey LB, Anne-Laure B et al (2007) Mouse model of in situ thromboembolic stroke and reperfusion. Stroke 38:2771\u20132778. https:\/\/doi.org\/10.1007\/978-1-4939-5620-3_6","journal-title":"Stroke"},{"key":"2644_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1161\/STROKEAHA.114.008407","volume":"46","author":"F Arnberg","year":"2015","unstructured":"Arnberg F, Grafstr\u00f6m J, Lundberg J et al (2015) Imaging of a clinically relevant stroke model glucose hypermetabolism revisited. Stroke 46:835\u2013842. https:\/\/doi.org\/10.1161\/STROKEAHA.114.008407","journal-title":"Stroke"},{"key":"2644_CR20","doi-asserted-by":"publisher","unstructured":"Gubern C, Comajoan P, Huguet G et al (2020) Evaluation of long-term rt-PA effects on bEnd.3 endothelial cells under ischemic conditions; changes in ZO-1 expression and glycosylation of the bradykinin B2 receptor. Thromb Res 187. https:\/\/doi.org\/10.1016\/j.thromres.2019.12.021","DOI":"10.1016\/j.thromres.2019.12.021"},{"key":"2644_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.brainres.2006.10.083","volume":"1130","author":"RC Brown","year":"2007","unstructured":"Brown RC, Morris AP, O\u2019Neil RG (2007) Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 1130:17\u201330. https:\/\/doi.org\/10.1016\/j.brainres.2006.10.083","journal-title":"Brain Res"},{"key":"2644_CR22","doi-asserted-by":"publisher","unstructured":"Comajoan P, Gubern C, Huguet G et al (2018) Evaluation of common housekeeping proteins under ischemic conditions and\/or rt-PA treatment in bEnd.3 cells. J Proteomics 184. https:\/\/doi.org\/10.1016\/j.jprot.2018.06.011","DOI":"10.1016\/j.jprot.2018.06.011"},{"key":"2644_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/(SICI)1099-081X(199803)19:2<131::AID-BDD87>3.0.CO;2-L","volume":"19","author":"KRKR Godfrey","year":"1998","unstructured":"Godfrey KRKR, Tanswell P, Bates RAR et al (1998) Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species: a comparison of mathematical models. Biopharm Drug Dispos 19:131\u2013140. https:\/\/doi.org\/10.1002\/(SICI)1099-081X(199803)19:2%3c131::AID-BDD87%3e3.0.CO;2-L","journal-title":"Biopharm Drug Dispos"},{"key":"2644_CR24","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm1787","volume":"14","author":"EJ Su","year":"2008","unstructured":"Su EJ, Fredriksson L, Geyer M et al (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731\u2013737. https:\/\/doi.org\/10.1038\/nm1787","journal-title":"Nat Med"},{"key":"2644_CR25","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1161\/STROKEAHA.116.013205","volume":"47","author":"KH Choi","year":"2016","unstructured":"Choi KH, Kim HS, Park MS et al (2016) Regulation of Caveolin-1 expression determines early brain edema after experimental focal cerebral ischemia. Stroke 47:1336\u20131343. https:\/\/doi.org\/10.1161\/STROKEAHA.116.013205","journal-title":"Stroke"},{"key":"2644_CR26","doi-asserted-by":"publisher","unstructured":"Chen S, Chen Z, Cui J et al (2018) Early abrogation of gelatinase activity extends the time window for tpa thrombolysis after embolic focal cerebral ischemia in mice. eNeuro 5. https:\/\/doi.org\/10.1523\/ENEURO.0391-17.2018","DOI":"10.1523\/ENEURO.0391-17.2018"},{"key":"2644_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1385\/1-59259-419-0:97","volume":"89","author":"S Nag","year":"2003","unstructured":"Nag S (2003) Pathophysiology of blood-brain barrier breakdown. Methods Mol Med 89:97\u2013119. https:\/\/doi.org\/10.1385\/1-59259-419-0:97","journal-title":"Methods Mol Med"},{"key":"2644_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/0271678X18806893","volume":"40","author":"C Blochet","year":"2020","unstructured":"Blochet C, Buscemi L, Cl\u00e9ment T et al (2020) Involvement of caveolin-1 in neurovascular unit remodeling after stroke: effects on neovascularization and astrogliosis. J Cereb Blood Flow Metab 40:163\u2013176. https:\/\/doi.org\/10.1177\/0271678X18806893","journal-title":"J Cereb Blood Flow Metab"},{"key":"2644_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9051313","volume":"9","author":"M Raeeszadeh-Sarmazdeh","year":"2020","unstructured":"Raeeszadeh-Sarmazdeh M, Do LD, Hritz BG (2020) Metalloproteinases and their inhibitors: potential for the development of new therapeutics. Cells 9:1\u201334. https:\/\/doi.org\/10.3390\/cells9051313","journal-title":"Cells"},{"key":"2644_CR30","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1161\/STROKEAHA.118.020683","volume":"49","author":"M Castellanos","year":"2018","unstructured":"Castellanos M, Van Eendenburg C, Gubern C et al (2018) Low levels of caveolin-1 predict symptomatic bleeding after thrombolytic therapy in patients with acute ischemic stroke. Stroke 49:1525\u20131527. https:\/\/doi.org\/10.1161\/STROKEAHA.118.020683","journal-title":"Stroke"},{"key":"2644_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9026787","author":"J Zhang","year":"2016","unstructured":"Zhang J, Zhu W, Xiao L et al (2016) Lower serum Caveolin-1 is associated with cerebral microbleeds in patients with acute ischemic stroke. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2016\/9026787","journal-title":"Oxid Med Cell Longev"},{"key":"2644_CR32","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1248\/bpb.b12-00915","volume":"36","author":"T Watanabe","year":"2013","unstructured":"Watanabe T, Dohgu S, Takata F et al (2013) Paracellular barrier and tight junction protein expression in the immortalized brain endothelial cell lines bend.3, bend.5 and mouse brain endothelial cell 4. Biol Pharm Bull 36:492\u2013495. https:\/\/doi.org\/10.1248\/bpb.b12-00915","journal-title":"Biol Pharm Bull"},{"key":"2644_CR33","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1523\/JNEUROSCI.6409-11.2012","volume":"32","author":"J Liu","year":"2012","unstructured":"Liu J, Jin X, Liu KJKJ, Liu W (2012) Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci 32:3044\u20133057. https:\/\/doi.org\/10.1523\/JNEUROSCI.6409-11.2012","journal-title":"J Neurosci"},{"key":"2644_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.brainres.2016.01.047","volume":"1636","author":"MC Yang","year":"2016","unstructured":"Yang MC, Zhang HZ, Wang Z et al (2016) The molecular mechanism and effect of cannabinoid-2 receptor agonist on the blood-spinal cord barrier permeability induced by ischemia-reperfusion injury. Brain Res 1636:81\u201392. https:\/\/doi.org\/10.1016\/j.brainres.2016.01.047","journal-title":"Brain Res"},{"key":"2644_CR35","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1210\/mend.14.11.0553","volume":"14","author":"H Lee","year":"2000","unstructured":"Lee H, Volonte\u2019 D, Galbiati F et al (2000) Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: Identification of a c-Src\/Cav-1\/Grb7 signaling cassette. Mol Endocrinol 14:1750\u20131775. https:\/\/doi.org\/10.1210\/mend.14.11.0553","journal-title":"Mol Endocrinol"},{"key":"2644_CR36","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1074\/jbc.271.7.3863","volume":"271","author":"S Li","year":"1996","unstructured":"Li S, Seitz R, Lisanti MP (1996) Phosphorylation of caveolin by Src tyrosine kinases: the \u03b1-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem 271:3863\u20133868. https:\/\/doi.org\/10.1074\/jbc.271.7.3863","journal-title":"J Biol Chem"},{"key":"2644_CR37","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1091\/mbc.E15-11-0756","volume":"27","author":"AMAM Zimnicka","year":"2016","unstructured":"Zimnicka AMAM, Husain YSYS, Shajahan ANAN et al (2016) Src-dependent phosphorylation of caveolin-1 Tyr-14 promotes swelling and release of caveolae. Mol Biol Cell 27:2090\u20132106. https:\/\/doi.org\/10.1091\/mbc.E15-11-0756","journal-title":"Mol Biol Cell"},{"key":"2644_CR38","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCRESAHA.109.201673","volume":"105","author":"Y Sun","year":"2009","unstructured":"Sun Y, Hu G, Zhang X, Minshall RDD (2009) Phosphorylation of caveolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and transcellular pathways. Circ Res 105:676\u2013685. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.201673","journal-title":"Circ Res"},{"key":"2644_CR39","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1007\/s00018-016-2301-3","volume":"73","author":"V Coelho-Santos","year":"2016","unstructured":"Coelho-Santos V, Socodato R, Portugal C et al (2016) Methylphenidate-triggered ROS generation promotes caveolae-mediated transcytosis via Rac1 signaling and c-Src-dependent caveolin-1 phosphorylation in human brain endothelial cells. Cell Mol Life Sci 73:4701\u20134716. https:\/\/doi.org\/10.1007\/s00018-016-2301-3","journal-title":"Cell Mol Life Sci"},{"key":"2644_CR40","doi-asserted-by":"publisher","unstructured":"Rui Q, Ni H, Lin X, et al (2019) Astrocyte-derived fatty acid-binding protein 7 protects blood-brain barrier integrity through a caveolin-1\/MMP signaling pathway following traumatic brain injury. Exp Neurol 322. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113044","DOI":"10.1016\/j.expneurol.2019.113044"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02644-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02644-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02644-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T21:25:11Z","timestamp":1645219511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02644-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["2644"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02644-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-551455\/v1","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"2 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed in accordance with the European Communities Council Directive (86\/609\/EEC) and approved by the Ethics Committee on Animal Welfare of University Complutense (PROEX No. 016\/18) and are reported according to ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All the authors verify that they concur with the present submission and that the material submitted has not been previously reported in any other journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}